Diagnosis Of Covid19 by PCR In Respiratory Symptoms by Triage in The Province of Manabí, Ecuador
Abstract
In late 2019, a new coronavirus emerged, causing the severe disease called severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2). Covid19 disease was diagnosed by PCR in respiratory symptomatic, by TRIAGE in Manabí Province, Ecuador. A descriptive study was performed in respiratory symptomatic patients between August 2020 and April 2021 in general medicine outpatient clinic of a public health care center. The presence of Sars-Cov-2 was evaluated by RT-PCR test. Of 275 cases attended, 48.7% were positive for COVID19 (Sars-Cov-2). The average time between the onset of symptoms and the positive result for SARCOV2 (Covid19) was 7.3 days. Male gender accounted for 51%, and the highest age range was between 40 and 51 years (25.1%). The highest number of occupations was composed of drivers, tailors, bricklayers, and street vendors (38.9%). In terms of symptoms, headache was present (64.4%), followed by malaise (52.4%) and cough (45.5%). Arterial hypertension was observed in (41.7%), and type 2 diabetes mellitus with (25%). The RTPCR test for Sars-Cov-2 is essential in the triage of respiratory patients with high suspicion of having Covid disease19.
Downloads
References
Díaz, F., & Toro, A. (2020). SARS-CoV-2/covid-19: el virus, la enfermedad y la pandemia. Medicina y Laboratorio., 24(3), 183–205.
Fadaka, A. O., Sibuyi, N. R. S., Adewale, O. B., Bakare, O. O., Akanbi, M. O., Klein, A., Madiehe, A. M., & Meyer, M. (2020). Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2. Journal of International Medical Research, 48(8). https://doi.org/10.1177/0300060520949077
Grant, M. C., Geoghegan, L., Arbyn, M., Mohammed, Z., McGuinness, L., Clarke, E. L., & Wade, R. G. (2020). The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARSCoV-2; COVID-19): A systematic review and meta- analysis of 148 studies from 9 countries. PLoS ONE, 15(6 June). https://doi.org/10.1371/journal.pone.0234765
Healy, B., Khan, A., Metezai, H., Blyth, I., & Asad, H. (2021). The impact of false positive COVID-19 results in an area of low prevalence. Clinical Medicine, Journal of the Royal College of Physicians of London, 21(1), E54–E56. https://doi.org/10.7861/
CLINMED.2020-0839
Kalantari, H., Tabrizi, A. H. H., & Foroohi, F. (2020). Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Reports, 21(August), 100910. https://doi.org/10.1016/j.genrep.2020.100910
Lema López, G. (2016). Hipertensión arterial y diabetes mellitus. Parroquia San Vicente, Manabí, Ecuador. Hipertensión Arterial y Diabetes Mellitus. Parroquia San Vicente, Manabí, Ecuador, 2(4), 28–39.
Mallett, S., Allen, A. J., Graziadio, S., Taylor, S., Sakai, N. S., Green, K., Suklan, J., Hyde, C., Shinkins, B., Zhelev, Z., Peters, J., Turner, P., Roberts, N. W., di Ruffano, L. F., Wolff, R., Whiting, P., Winter, A., Bhatnagar, G., Nicholson, B. D., & Halligan, S. (2020). At what times during infection is SARSCoV‐2 detectable and no longer detectable using RT-PCR based tests?: A systematic review of individual participant data. BMC Medicine, 1–17.
https://doi.org/10.1101/2020.07.13.20152793
Mao, Y., Jones, R. M., Tan, Q., Ji, J. S., Li, N., Shen, J., Lv, Y., Pan, L., Ding, P., Wang, X., Wang, Y., & Macintyre, C. R. (2020). Aerosol transmission of SARS-CoV-2? Evidence, prevention and control Song. Environment International, 144(January), 1–10.
Mutambudzi, M., Niedwiedz, C., Macdonald, E. B., Leyland, A., Mair, F., Anderson, J., Celis-Morales, C., Cleland, J., Forbes, J., Gill, J., Hastie, C., Ho, F., Jani, B., Mackay, D. F., Nicholl, B., O’donnell, C., Sattar, N., Welsh, P., Pell, J. P., … Demou, E. (2021). Occupation and risk of severe COVID-19: Prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78(5), 307–314. https://doi.org/10.1136/oemed-2020-106731
Ortiz-Prado, E., & Fernández-Naranjo, R. (2020). Impact of COVID-19 in ecuador: From inaccurate data to using excess mortality. Revista Ecuatoriana de Neurología, 29(2), 8–11. https://doi.org/10.46997/REVECUATNEUROL29200008
Shaffaf, T., & Ghafar-Zadeh, E. (2021). Covid-19 diagnostic strategies. Part i: Nucleic acid-based technologies. Bioengineering, 8(4), 1–29. https://doi.org/10.3390/bioengineering8040049
Tadic, M., & Cuspidi, C. (2021). The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges? Journal of Clinical Hypertension, 23(2), 235–237. https://doi.org/10.1111/jch.14145
Vijay, R., & Perlman, S. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’ s public news and information. January.
Copyright
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right to be the first publication where the article is submitted, which is published under a Creative Commons Attribution License, which allows others to share the work upon acknowledgment of authorship of the work and initial publication in this journal.
Authors may separately enter into additional agreements for non-exclusive distribution of the version of the work published in the journal (e.g., placing it in an institutional repository or publishing it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under the license:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
3.png)
_.jpg)
_(1).jpg)
1.jpg)
